Carlos Aydillo Miguel-rekin lankidetzan egindako argitalpenak (11)

2023

  1. First Generation of Antioxidant Precursors for Bioisosteric Se-NSAIDs: Design, Synthesis, and In Vitro and In Vivo Anticancer Evaluation

    Antioxidants, Vol. 12, Núm. 9

2022

  1. Norbornene and Related Structures as Scaffolds in the Search for New Cancer Treatments

    Pharmaceuticals, Vol. 15, Núm. 12

2021

  1. Library of selenocyanate and diselenide derivatives as in vivo antichagasic compounds targeting trypanosoma cruzi mitochondrion

    Pharmaceuticals, Vol. 14, Núm. 5

  2. New amides and phosphoramidates containing selenium: Studies on their cytotoxicity and antioxidant activities in breast cancer

    Antioxidants, Vol. 10, Núm. 4

  3. New amides containing selenium as potent leishmanicidal agents targeting trypanothione reductase

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 1

  4. New phosphoramidates containing selenium as leishmanicidal agents

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 10

2020

  1. Development and Therapeutic Potential of Selenazo Compounds

    Journal of Medicinal Chemistry, Vol. 63, Núm. 4, pp. 1473-1489

  2. New formulation of a methylseleno-aspirin analog with anticancer activity towards colon cancer

    International Journal of Molecular Sciences, Vol. 21, Núm. 23, pp. 1-17

  3. Novel n,n′-disubstituted acylselenoureas as potential antioxidant and cytotoxic agents

    Antioxidants, Vol. 9, Núm. 1

  4. Vilsmeier reagent, NaHSe and diclofenac acid chloride: One-pot synthesis of a novel selenoindolinone with potent anticancer activity

    RSC Advances, Vol. 10, Núm. 63, pp. 38404-38408

2018

  1. Novel selenadiazole derivatives as selective antitumor and radical scavenging agents

    European Journal of Medicinal Chemistry, Vol. 157, pp. 14-27